ADCETRIS Brentuximab Vedotin Injection

What is Adcetris (Brentuximab Vedotin) Adcetris (Brentuximab Vedotin) is the first approved CD-30 directed antibody drug conjugate


Drug Manufacturer / Marketeer :


Available as:


Indications: Adcetris® (Brentuximab Vedotin) injection for intravenous infusion is indicated for the treatment of:

  • Hodgkins Lymphoma after failure of autologous stem cell transplant (ASCT)
  • Hodgkins Lymphoma in patients who are not ASCT candidates after failure of at least 2 multiagent chemotherapy regimens
  • Systemic anaplastic large cell lymphoma after failure of at least 1 multiagent chemotherapy regimen

Treatment: For treatment related information, please consult your treating Physician.

How supplied: Adcetris powder for infusion 50 mg vial

Storage and handling: Store at 2°- 8° C

How do we source the Drug?

SMIQ Pharma-India will assist in sourcing the drug through its efficient network,  across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.

Company that Manufactures/ Markets: M/s Seattle Genetics, inc.

Assistance Cell in India: For ONCOLOGY DRUG: ADCETRIS (Brentuximab Vedotin) 50 mg price.

Contact us @ +91 7678048225 or by email